Literature DB >> 2970891

Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients.

M Eura1, T Maehara, T Ikawa, T Ishikawa.   

Abstract

Cytotoxicity was induced in lymphocytes (CL) from 10 out of 15 patients by autologous mixed lymphocyte tumor cell culture and further cultivation with recombinant interleukin-2. In cells from 3 of the 10 patients, cytotoxicity was suppressed by more than 50% when autologous peripheral blood mononuclear cells (PBMC) from the patients with large tumors were added to the autologous killing system. The cells responsible for suppressing the cytotoxicity in the effector phase were adherent or nonadherent to plastic depending on the patient examined. The T cell fraction from 1 patient significantly suppressed the cytotoxic activity, and this suppression was seen only in the autologous system. On the other hand, plastic adherent cells but not T cells from PBMC of 2 subjects suppressed the cytotoxic activity of CL. The reason why the main cell population suppressing the CL activity differed among the patients is unclear. However, the findings that the suppression was mostly abrogated following resection of the tumor mass suggested that suppressor cells, either of macrophage lineage or T cells, are induced in patients with a large tumor mass. This speculation is supported by the finding that the PBMC from a patient with tumor recurrence regained the suppressive activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970891     DOI: 10.1007/bf00200020

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  29 in total

1.  Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.

Authors:  L Varesio; M Giovarelli; S Landolfo; G Forni
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

2.  Cryopreservation of human lymphocyte function as measured by in vitro assays.

Authors:  R K Oldham; J H Dean; G B Cannon; J R Ortaldo; G Dunston; F Applebaum; J L McCoy; J Djeu; R B Herberman
Journal:  Int J Cancer       Date:  1976-08-15       Impact factor: 7.396

3.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

4.  Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation.

Authors:  M B Mokyr; D P Braun; S Dray
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

5.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

Authors:  K Kumagai; K Itoh; S Hinuma; M Tada
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

6.  Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2.

Authors:  B M Vose; G D Bonnard
Journal:  Int J Cancer       Date:  1982-01-15       Impact factor: 7.396

7.  Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.

Authors:  A Yu; H Watts; N Jaffe; R Parkman
Journal:  N Engl J Med       Date:  1977-07-21       Impact factor: 91.245

8.  Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor.

Authors:  Y Ichino; T Ishikawa
Journal:  Gan       Date:  1984-05

9.  Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression.

Authors:  C C Ting; M E Hargrove
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

10.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

Authors:  F Vánky; T Gorsky; Y Gorsky; M G Masucci; E Klein
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  3 in total

1.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes.

Authors:  K Chikamatsu; M Eura; H Matsuoka; H Murakami; T Fukiage; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

3.  Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.

Authors:  B Leshem; E Kedar
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.